Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Express Scripts
Merck
Moodys
McKinsey

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Litigation Details for Laboratoire HRA Pharma v. Teva Pharmaceuticals USA Inc. (D. Del. 2015)

See Plans and Pricing

« Back to Dashboard

Laboratoire HRA Pharma v. Teva Pharmaceuticals USA Inc. (D. Del. 2015)

Docket   Start Trial Date Filed 2015-01-16
Court District Court, D. Delaware Date Terminated 2016-08-08
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties LABORATOIRE HRA PHARMA; TEVA PHARMACEUTICALS USA INC.
Patents 8,426,392; 8,512,745; 8,735,380; 8,962,603; 9,283,233
Attorneys Alexander E. Gasser; Brian E. Farnan; Joseph J. Farnan , Jr.; Karen Elizabeth Keller; Michael J. Farnan; Paul J. Skiermont; Sarah E. Spires
Link to Docket External link to docket
Small Molecule Drugs cited in Laboratoire HRA Pharma v. Teva Pharmaceuticals USA Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Laboratoire HRA Pharma v. Teva Pharmaceuticals USA Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-01-16 1 expiration of U.S. Patent Nos. 8,426,392 (the “’392 patent”); 8,512,745 (the “’745 patent”); and 8,735,380…Paragraph IV Certification Concerning U.S. Patent Nos. 8,426,392, 8,512,745 And 8,735,380” (“Notice Letter…This action is for patent infringement arising under the Food and Drug Laws and Patent Laws of the United…,380 (the “’380 patent”) (collectively, the “patents-in-suit”). …. This civil action for patent infringement arises under the patent laws of the United States, including External link to document
2015-01-16 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,426,392 B2; US 8,512,745 …2015 8 August 2016 1:15-cv-00045 830 Patent None District Court, D. Delaware External link to document
2016-03-21 81 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,426,392 B2; US 8,512,745 …2015 8 August 2016 1:15-cv-00045 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Express Scripts
Baxter
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.